SOPHiA GENETICS SA
General ticker "SOPH" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $229.1M (TTM average)
SOPHiA GENETICS SA follows the US Stock Market performance with the rate: 48.3%.
Estimated limits based on current volatility of 3.4%: low 4.92$, high 5.27$
Factors to consider:
- Total employees count: 518 as of 2021
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.97$, 4.63$]
- 2025-12-31 to 2026-12-31 estimated range: [1.78$, 4.19$]
Financial Metrics affecting the SOPH estimates:
- Positive: with PPE of -3.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -20.23 <= 0.33
- Negative: negative Net income
- Positive: 41.86 < Shareholder equity ratio, % of 62.13 <= 63.39
- Positive: -4.48 < Investing cash flow per share per price, % of -3.86
- Negative: negative Industry operating cash flow (median)
Short-term SOPH quotes
Long-term SOPH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $47.56MM | $62.37MM | $65.17MM |
| Operating Expenses | $135.38MM | $137.20MM | $131.74MM |
| Operating Income | $-87.82MM | $-74.83MM | $-66.57MM |
| Non-Operating Income | $0.24MM | $-3.67MM | $5.30MM |
| Interest Expense | $0.64MM | $0.59MM | $1.91MM |
| R&D Expense | $35.37MM | $36.97MM | $34.37MM |
| Income(Loss) | $-87.58MM | $-78.50MM | $-61.27MM |
| Profit(Loss)* | $-87.45MM | $-78.98MM | $-62.49MM |
| Stockholders Equity | $200.13MM | $151.44MM | $96.49MM |
| Inventory | $5.16MM | $6.48MM | $5.87MM |
| Assets | $243.84MM | $206.16MM | $155.31MM |
| Operating Cash Flow | $-70.09MM | $-48.58MM | $-42.82MM |
| Capital expenditure | $10.38MM | $9.23MM | $8.18MM |
| Investing Cash Flow | $41.97MM | $8.32MM | $-8.18MM |
| Financing Cash Flow | $-1.57MM | $-2.82MM | $11.59MM |
| Earnings Per Share** | $-1.36 | $-1.22 | $-0.95 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.